Breaking News

 
10 March 2010
Update on the EDEN survey on comparators, durations, outcomes and sponsorship of psoriasis trials
 
08 March 2010
Psoriasis associated with hepatitis C but not hepatitis B
 
06 March 2010
Use of biological agents in psoriatic disease: An Italian perspective
 
05 March 2010
Safety and efficacy of tacrolimus and pimecrolimus in atopic dermatitis patients previously treated with corticosteroids
 
04 March 2010
Psoriasis patients’ satisfaction with topical therapy using a calcipotriol/betamethasone formulation in clinical practice
 
03 March 2010
Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy
 
02 March 2010
Relationship between hand eczema and nickel allergy: Results from two cross-sectional Danish studies
 
02 March 2010
Development and validation of a nail psoriasis quality of life scale
 
26 February 2010
Matrix metalloproteinase expression in atopic dermatitis
 
25 February 2010
Open-label, single-center pilot study to evaluate antifungal activity of a novel nonsteroidal cream in volunteers
 
24 February 2010
Topical tacrolimus for treatment-resistant cutaneous lupus erythematosus
 
23 February 2010
Retreatment with alitretinoin in previously relapsed patients with chronic hand eczema
 
22 February 2010
Association between frequency of pruritic symptoms and perceived psychological stress
 
19 February 2010
Late-onset IgE sensitization to microbial allergens in pediatric atopic dermatitis
 
18 February 2010
Ustekinumab improves quality of life in patients with moderate-severe psoriasis
 
17 February 2010
Skin barrier function and current perception threshold in extrinsic and intrinsic atopic dermatitis
 
16 February 2010
A randomized controlled trial in pediatric eczema: Quality of life outcomes by nurse practitioners versus dermatologists
 
15 February 2010
Miltefosine versus clobetasol in mastocytosis: Controlled study
 
09 February 2010
Polyphenon E®: A novel treatment for external anogenital warts
 
05 February 2010
Quality of life evaluation in epidermolysis bullosa: Development of a specific quality of life instrument